Unbiased Drug Selection for Audit Using Distributed Ledger Technology
AssigneeOMNY, Inc.
InventorSean O'Brien
Life of this patent
Estimating the term…
Loading patent…
AssigneeOMNY, Inc.
InventorSean O'Brien
Estimating the term…
A computer-implemented method of auditing drug supply chain data gathered from a distributed ledger is disclosed. The method includes receiving a population of drug product records from the distributed ledger. The method includes receiving a first set of drug product criteria. The method includes determining a weighted probability for one or more drug product records of the population of drug product records. The method includes generating a randomized first subset of drug product records from the population of drug product records based on the weighted probability of the one or more drug product records. Other methods, systems, and the like for unbiased drug selection for audit are also disclosed.
A computer-implemented method of auditing drug supply chain data gathered from a distributed ledger, comprising:
A computer-implemented method of auditing drug supply chain data gathered from a distributed ledger, comprising:
A computer-implemented method of auditing drug supply chain data gathered from a distributed ledger, comprising:
Dependencies are inferred from the claim text.